Back to Centiva Capital, LP Centiva Capital, LP

CTSOCTSO

2 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in Cytosorbents Corporation

No. Centiva Capital exited its CTSO (Cytosorbents) position in Q4 2025. Its Q3 2025 13F listed 10,737 shares worth $10,029. Centiva Capital first reported CTSO in Q3 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$10,029

Total Shares Change

-10,737

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$12.78
0
2025-Q3
New
10,737
—
$10,0290.0%$18.68
24

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used